mannose has been researched along with Black Fever in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 11 (47.83) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdhuri, S; Das, BK; Das, D; Das, S; Dowari, P; Kushwaha, R; Roy, S; Ukil, A | 1 |
| Akhtar, S; Farhan Sohail, M; Sarwar, M; Satoskar, AR; Shahnaz, G; Shoaib Sarwar, H; Varikuti, S | 1 |
| Chaubey, P; Chaurasia, S; Mishra, B; Monteiro, M; Mudavath, SL; Patel, RR; Sundar, S; Suvarna, V | 1 |
| Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Chaubey, P; Mishra, B | 1 |
| Chaubey, P; Mishra, B; Patel, RR | 1 |
| Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M | 1 |
| Dube, A; Dubey, V; Jain, NK; Mishra, D; Mishra, PK; Nahar, M | 1 |
| Gulbake, A; Jain, A; Jain, SK; Khare, P; Rathore, A; Shilpi, S | 1 |
| Das, L; Das, PK; Datta, N; Mukherjee, S | 1 |
| Chatterjee, TK; Das, N; Mandal, AK; Mitra, M | 1 |
| Banerjee, G; Basu, MK; Bhaduri, AN | 1 |
| Bandyopadhyay, R; Basu, MK; Dutta, M | 1 |
| Das, PK; Sarkar, K; Sett, R | 1 |
| Basu, MK; Das, N; Mahato, SB; Medda, S; Mukherjee, S; Naskar, K | 1 |
| Das, PK; Sarkar, HS; Sett, R | 1 |
| Banerjee, G; Basu, MK; Mahato, SB; Nandi, G; Pakrashi, A | 1 |
| Bernardo, RR; Palatnik de Sousa, CB; Palatnik, M; Parente, JP; Peçanha, LM; Santos, WR | 1 |
| Basu, MK; Medda, S; Mukhopadhyay, S; Raay, B | 1 |
| Basu, N; Das, PK; Sett, R | 1 |
| Bhaduri, AN; Chakraborty, P; Das, PK | 1 |
| Basu, MK; Das, N; Ghosh, DK; Mahato, SB; Naskar, K | 1 |
| Chakraborty, P; Das, PK | 1 |
23 other study(ies) available for mannose and Black Fever
| Article | Year |
|---|---|
Mannose-Decorated Composite Peptide Hydrogel with Thixotropic and Syneresis Properties and its Application in Treatment of Leishmaniasis.
Topics: Humans; Hydrogels; Leishmaniasis; Leishmaniasis, Visceral; Mannose; Peptides | 2022 |
Oral delivery and enhanced efficacy of antimonal drug through macrophage-guided multifunctional nanocargoes against visceral Leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Humans; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Particle Size | 2020 |
Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Topics: Cell Line; Chitosan; Curcumin; Drug Carriers; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles | 2018 |
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution | 2018 |
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin | 2014 |
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemistry, Pharmaceutical; Chitosan; Curcumin; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Leishmaniasis, Visceral; Male; Mannose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2014 |
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles | 2017 |
In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Carriers; Gelatin; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles | 2010 |
Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cations; Cricetinae; Female; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mannose; Mesocricetus; Molecular Structure | 2011 |
Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; CpG Islands; Cricetinae; Drug Delivery Systems; Endocytosis; Immunity, Innate; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukins; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Lymphocyte Activation; Macrophages, Peritoneal; Mannose; Mice; Mice, Inbred BALB C; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides; Spleen; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha | 2003 |
Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.
Topics: Animals; Anthraquinones; Antiprotozoal Agents; Benzyl Compounds; Concanavalin A; Cricetinae; Drug Carriers; Drug Delivery Systems; Excipients; Fluoresceins; Fluorescent Dyes; Intercalating Agents; Kidney Function Tests; Leishmaniasis, Visceral; Liposomes; Liver Function Tests; Macrophages; Mannose; Mesocricetus; Mice; Mice, Inbred BALB C; Mononuclear Phagocyte System; Particle Size; Penicillium; Trinitrobenzenesulfonic Acid; Trypan Blue | 2005 |
Mannose-coated liposomal hamycin in the treatment of experimental leishmaniasis in hamsters.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Leishmaniasis, Visceral; Liposomes; Macrophages; Mannose; Polyenes; Surface Properties | 1994 |
Neoglycosylated liposomes as efficient ligands for the evaluation of specific sugar receptors on macrophages in health and in experimental leishmaniasis.
Topics: Animals; Carrier Proteins; Down-Regulation; Drug Carriers; Galactose; Glucose; Humans; Lectins, C-Type; Leishmania donovani; Leishmaniasis, Visceral; Ligands; Liposomes; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Spleen | 1994 |
Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
Topics: Animals; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Glycoproteins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Serum Albumin | 1993 |
Sugar-coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Carriers; Drug Compounding; Glucose; Glycosides; Leishmaniasis, Visceral; Liposomes; Liver; Macrophages; Male; Mannose; Mesocricetus; Mice; Organometallic Compounds; Urea | 1993 |
Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
Topics: Animals; Disease Models, Animal; Humans; In Vitro Techniques; Leishmaniasis, Visceral; Liver; Macrophages; Mannose; Methotrexate; Mice; Mice, Inbred BALB C; Serum Albumin; Subcellular Fractions; Tissue Distribution | 1993 |
Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antiprotozoal Agents; Cricetinae; Drug Delivery Systems; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Liver Function Tests; Mannose; Mesocricetus; Pentamidine | 1996 |
Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani.
Topics: Adjuvants, Immunologic; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cricetinae; Fucose; Hemolysin Proteins; Humans; Lectins; Leishmania donovani; Leishmaniasis, Visceral; Ligands; Mannose; Mice; Mice, Inbred BALB C; Plant Extracts; Saponins | 1997 |
Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis.
Topics: Alkaloids; Animals; Antiprotozoal Agents; Benzodioxoles; Cricetinae; Drug Carriers; Leishmaniasis, Visceral; Liposomes; Liver Function Tests; Macrophages; Mannose; Mesocricetus; Piperidines; Polyunsaturated Alkamides; Spleen | 1999 |
Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani.
Topics: Animals; Cycloheximide; Down-Regulation; Kinetics; Kupffer Cells; Lectins, C-Type; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Receptors, Immunologic | 1991 |
Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis.
Topics: Animals; Cells, Cultured; Drug Carriers; Kinetics; Lectins, C-Type; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Methotrexate; Mice; Mice, Inbred BALB C; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Immunologic; Serum Albumin; Serum Albumin, Bovine | 1990 |
Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Drug Carriers; Leishmaniasis, Visceral; Liposomes; Mannose; Mesocricetus; Mononuclear Phagocyte System; Organometallic Compounds; Urea | 1990 |
Role of mannose/N-acetylglucosamine receptors in blood clearance and cellular attachment of Leishmania donovani.
Topics: Acetylglucosamine; Animals; Cricetinae; Glycoproteins; Lectins; Lectins, C-Type; Leishmania donovani; Leishmaniasis, Visceral; Liver; Macrophages; Male; Mannose; Mannose Receptor; Mannose-Binding Lectins; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Spleen; Tunicamycin | 1988 |